metricas
covid
Neurology perspectives Most often read
Journal Information

Most often read

12859
Ibero-American consensus statement on migraine treatment
José Miguel Láinez, Oscar Pradilla, Pablo Irimia, Fidel Sobrino, Michel Volcy, Pedro Kowaks, Ildefonso Rodríguez Leyva, Fiorella Martín, ... Alex Espinoza
12859
Full text access
7619
Functional cognitive disorder: Beyond pseudodementia
D.S. Marín-Medina, P.A. Arenas-Vargas, M. del Pilar Velásquez-Duque, P.M. Bagnati
7619
Full text access
4246
Bridging the gap: Unveiling the gut's influence on Parkinson's disease through probiotic interventions
A.Y. Nápoles-Medina, B.R. Aguilar-Uscanga, B.G. Nápoles-Medina, P.A. Brand-Rubalcava, A.R. Tejeda-Martínez, M.E. Flores-Soto
4246
Full text access
2517
Neurotoxicity of aluminium chloride and okadaic acid in zebrafish: Unravelling Alzheimer's disease model via learning and memory function evaluation
S.Z. Raduan, Q.U. Ahmed, M.R.A. Rusmili, A.S.M. Sabere, M.S. Haris, M.F. Shaikh, W.A.W. Sulaiman, M.H. Mahmood
2517
Full text access
2324
Inflammatory bowel disease and multiple sclerosis
M. Dominguez-Gallego, V. Meca-Lallana, A.B. Caminero
2324
Full text access
2260
Myasthenic crisis probably triggered by local lidocaine infiltration unveiling generalized myasthenia gravis without extraocular muscle involvement
M. León-Ruiz, C. Rízea, J. Álvarez-Troncoso, M. Quintana-Díaz, G. Zmork-Martínez, J. Benito-León, J. Rodríguez-Pardo
2260
Full text access
2174
Late-onset myoclonic epilepsy in Down syndrome (LOMEDS) and efficacy of perampanel
Nazaret Peláez Vina, D.D. Bórquez, E.N. Moral, M. Cáceres
2174
Full text access
1924
Autoimmune eye diseases in multiple sclerosis
M.L. Martínez Ginés, P. Rojas Lozano
1924
Full text access
1855
Other autoimmune diseases and multiple sclerosis
S. Martínez-Yélamos, Á. Pérez-Sempere
1855
Full text access
1844
Cough headache associated with CANVAS: A case report
E. Martínez-Campos, M. San Miguel, M. Martín Bujanda
1844
Full text access
1498
Retrospective, multi-centre, open-label study on the use of alemtuzumab for relapsing–remitting multiple sclerosis in clinical practice: A 4-year follow-up
A. Pato-Pato, P. Gabeiras-Araujo, M. Lorenzo-García, C. Hernandez-Cerón, J.R. Lorenzo-González, D.A. García-Estévez
1498
Full text access
1471
Autoimmune skin diseases in multiple sclerosis
M. Roncero Riesco, A. Cabanillas Cabral, Y. El Berdei Montero
1471
Full text access
1413
Multiple sclerosis and rheumatic diseases: Behçet disease, sarcoidosis, and Sjögren syndrome
M.A. Hernández, Y. Contreras, B. González, L.M. Armas
1413
Full text access
1405
Impact of COVID-19 on physiotherapy for patients with multiple sclerosis in Spain: Adaptation and challenges in the implementation of telerehabilitation
I. Yeregui-Prieto, R. Berriozabalgoitia Etxaniz, N. Martínez Lerín, G. Yaya-Tur, G. Loyola, E.R. Meza-Murillo, C. Santoyo-Medina
1405
Full text access
1379
Transient receptor potential (TRP) in neuroglia and their role in pain. Brief review
L. Arce Gálvez, J.M. Mancera Álzate, M.F. Rosero Chamorro, Á.J. Tellez Pérez, A.F. Ausenón, J.D. Cardona Bahamon, L.M. Rodriguez Vélez
1379
Full text access
Article options
Tools